
Informations and discussions about nicotine, tobacco, smoking cessation, new nicotine and tobacco products (electronic cigarettes, heated tobacco, snus, nicotine pouches, etc.)
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 10 | Founded | a year ago | Last Issue | 6 months ago |
| Active | |||||

The World Health Organisation (WHO) has just published a summary document on tobacco control and harm reduction, a few days before the opening of the Conference of the Parties to the Framework Convention on Tobacco Control (FCTC COP-11), wh...
I would like to draw your attention to a major problem in the preparatory documents drafted by the FCTC Secretariat for COP-11 delegates : the improper reframing of the FCTC’s objective to include nicotine use instead of targeting tobacco c...
The 11th Conference of the Parties to the WHO Framework Convention on Tobacco Control (FCTC COP-11) will be held in Geneva in a few days. The preparatory documents prove once again that FCTC leaders have abandoned any pretence of a scientif...
Philip Morris International (PMI) has just published its quarterly results. Most of its volume growth is now attributable to smokeless products, which are more profitable than combustible products. In Japan, heated tobacco now has the same...
Cytisine is a safe, effective and cheap smoking cessation drug that was just added to WHO’s list of essential medicines. It is the first smoking cessation drug to be added to this list in two decades (the last ones were varenicline and bupr...
Subscribers, engagement, traffic and sponsorship for Nicotine, tobacco and smoking cessation.
| Subscribers | Engagement | 77 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
I am an honorary (retired) professor of public health at the University of Geneva, author of over 180 peer-reviewed scientific articles, mostly on nicotine, tobacco, smoking cessation and e-cigarettes. I have no conflict of interest.
You can find recent issues that have been published by Nicotine, tobacco and smoking cessation on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Nicotine, tobacco and smoking cessation, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Nicotine, tobacco and smoking cessation as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Nicotine, tobacco and smoking cessation using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Nicotine, tobacco and smoking cessation. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.